Research Interests
Cancer TherapyMs Ifeoma Dikeocha
School of Pharmacy and Biomedical Science
College of Health
Experienced cancer researcher with a focus on preclinical models and cancer pharmacology. Currently a Postgraduate Research Candidate at the University of Adelaide's Cancer Treatment and Toxicities Group, I specialize in developing chemotherapy models in animal studies, proficient in tissue analysis, immunohistochemistry, and histology. My work has resulted in peer-reviewed publications, conference proceedings, and a review paper.As a former Postgraduate Research Assistant at the University of Malaya, I developed expertise in cancer cell and bacterial cultures, as well as in vivo treatments to assess probiotic impacts on cancer cells. I authored multiple research articles and reviews, contributing to advancements in integrative cancer research.In addition to research, I am a tutor in Nursing and Health Sciences at the University of Adelaide, designing and delivering engaging courses on public health and medical science topics. My teaching emphasizes accessibility and interactive learning, supporting students’ comprehension and success through well-structured content and assessments.I also enjoy engaging with my peers and fostering relationships hence i am part of the health science postgraduate association with fosters peer to peer connection amongst students in the faculty of health and medical sciences.
Ifeoma's research focuses on the effect of diet and the gut microbiota on breast cancer tumor response to chemotherapy. Her research looks at how a novel diet affects the tumor size in a cyclical chemotherapy model and how these diets mitigate the chemotherapy side effects and improve overall survival. She is passionate about improving HDR experiences by peer-to-peer support.
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2019 - 2021 | Cyberjaya University College of Medical Sciences | Malaysia | M.Sc., Medical Science (By Research) |
| 2011 - 2015 | University of Port Harcourt | Nigeria | B.Sc., Microbiology |
| Year | Citation |
|---|---|
| 2024 | Dikeocha, I. J., Wardill, H. R., Coller, J. K., & Bowen, J. M. (2024). Dietary interventions and tumor response to chemotherapy in breast cancer: A comprehensive review of preclinical and clinical data. Clinical Nutrition Espen, 63, 462-475. Scopus1 WoS1 Europe PMC1 |
| 2023 | Dikeocha, I. J., Al-Kabsi, A. M., Ahmeda, A. F., Mathai, M., & Alshawsh, M. A. (2023). Investigation into the Potential Role of Propionibacterium freudenreichii in Prevention of Colorectal Cancer and Its Effects on the Diversity of Gut Microbiota in Rats. International Journal of Molecular Sciences, 24(9), 8080-1-8080-15. Scopus10 WoS9 Europe PMC5 |
| 2022 | Dikeocha, I. J., Al-Kabsi, A. M., Miftahussurur, M., & Alshawsh, M. A. (2022). Pharmacomicrobiomics: Influence of gut microbiota on drug and xenobiotic metabolism. FASEB Journal, 36(6), 14 pages. Scopus56 WoS47 Europe PMC41 |
| 2022 | Dikeocha, I. J., Al-Kabsi, A. M., Eid, E. E. M., Hussin, S., & Alshawsh, M. A. (2022). Probiotics supplementation in patients with colorectal cancer: A systematic review of randomized controlled trials. Nutrition Reviews, 80(1), 22-49. Scopus49 WoS41 Europe PMC34 |
| 2022 | Dikeocha, I. J., Al-Kabsi, A. M., Chiu, H. -T., & Alshawsh, M. A. (2022). Faecalibacterium prausnitzii Ameliorates Colorectal Tumorigenesis and Suppresses Proliferation of HCT116 Colorectal Cancer Cells. Biomedicines, 10(5), 1128-1-1128-15. Scopus69 WoS67 Europe PMC60 |
| 2020 | Dikeocha, I. J., Al-Kabsi, A. M., Hussin, S., & Alshawsh, M. A. (2020). Role of probiotics in patients with colorectal cancer: a systematic review protocol of randomised controlled trial studies. BMJ Open, 10(8), e038128-1-e038128-5. Scopus10 WoS11 Europe PMC8 |
| Year | Citation |
|---|---|
| - | Dikeocha, I. J., Al-Kabsi, A. M., Hussin, S., & Alshawsh, M. A. (2021). Probiotic Administration Ameliorate Azoxymethane Induced-Carcinogenesis by Reducing the Formation of Aberrant Crypt Foci and Modulation Oxidative Stress in Rats. In The 1st International Electronic Conference on Biomedicine (pp. 21). MDPI. DOI |
| Year | Citation |
|---|---|
| - | Dikeocha, I. (n.d.). Dark Agouti tumor data. DOI |
Ifeoma's Research is funded by industry partner Nutricia, which has a long-standing arrangement with the university.
Ifeoma is currently involved in Lecturing, Tutoring and Lab demonstrations for Physiology courses and the university preparatory courses for the health and medical science cohort on a Part time basis.
- Tutor/Lab demonstrator Physiology IIA: Heart, Lung & Neuromuscular Systems
- Lecturer/ Tutor EDUC 1014 Nursing & Health Sciences
- Tutor/Lab demonstrator Physiology IIB: Systems & Homeostasis
- Tutor Human Anatomy and Physiology at University of Adelaide College
- Project Supervisor—Bachelor of health and medical sciences 2025 cohort
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2024 - ongoing | Convener | Australian Society for Medical Research Gala Dinner | University Of Adelaide | Australia |
| 2023 - ongoing | Vice-President | Australasian Human Microbiome Research Network | University of Adelaide | Australia |
| 2023 - 2024 | Vice-President | Health Sciences Postgraduate Association (HeSPA | University of Adelaide | Australia |
| Date | Office Name | Institution | Country |
|---|---|---|---|
| 2024 - 2025 | President | Health Sciences Postgraduate Association (HeSPA) | Australia |
Connect With Me
External Profiles
